Tag Archives: Early Differential Diagnosis

Functional Memory Disorders: a Potential Reason for Dementia Misdiagnoses? (BJGP)

Posted on May 8, 2019 by Dementia and Elderly Care News

Summary The authors of this review speculate whether a proportion of persons receiving referrals to memory clinics may not have dementia (or perhaps not even pre-clinical neurodegenerative disease at all); this category of patients may instead have functional disorders of … Continue reading →

Posted in Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), NHS, Quick Insights, UK, Universal Interest | Tagged Ability to Answer Multi-Part Questions, Accounts and Metaphor, Alzheimer Phobia (Speculative Construct), Alzheimer's Disease: Diagnosis, Anosognosia, Assessment and Diagnosis, Assessment of Cognition During Natural Interaction, Attending Alone, Autobiographical Information, Awareness of Repetition, BJGP: British Journal of General Practice, British Journal of General Practice, Cognitive Assessments to Help Differentiate Between Dementia and Functional Disorders of Memory, Cognitive Decline and Dementia, Companion Involvement, Compensatory Strategies: Humour, Competent Identity, Conversation Analysis, Conversation Analysis in Differential Diagnosis of Memory Problems, Conversation Analytic (CA) Interventions, Conversational Assessment in Memory Clinic Encounters, Dementia Diagnosis, Dementia-Related Misdiagnosis, Depressive Pseudo-Dementia, Differential Diagnosis, Differential Diagnosis of Memory Problems, Dominant Humour, Early Differential Diagnosis, East London Foundation Trust, Face-Saving Behaviour, Features of Communication to Discriminate Between Neurodegenerative and Functional Memory Disorders, Forgetful Identity, Functional Memory Disorder (FMD), General Practitioner Assessment of Cognition, Head Turning Sign (HTS), Homerton Psychological Medicine (East London), I Don’t Know (IDK) Responses, Knowledge Reinforcing Tokens, Medically Unexplained Symptoms (MUS), Memory Clinics, Mild Cognitive Impairment (MCI), Neuropsychiatry Service: St George's Hospital (London), Patient Ability to Answer and Participate in Consultation, Prodromal Dementia, Quick Relevant Detailed and Unsolicited accounts of Memory Problems, Referral to Memory Clinics: Assessment, Requesting Companion Confirmation, Sheffield Institute for Translational Neuroscience (SITraN): University of Sheffield, South West London and St George’s Mental Health NHS Trust, St George's Hospital (London), Subjective Cognitive Complaints, University of Sheffield, Working Memory Within the Interaction (Refering to Things Said Earlier) | Leave a comment

Cognitive Assessment: Differentiating the Three Ds “Dementia, Delirium and Depression” (Nursing Times / University of Stirling DSDC)

Posted on April 18, 2015 by Dementia and Elderly Care News

Summary Nursing Times Learning has produced a new learning unit to assist in the differential diagnosis between dementia, delirium and depression in older people. The aim is to offer training / continuing professional development which helps ensure patients receive the … Continue reading →

Posted in Alzheimer's Society, Charitable Bodies, Delirium, Depression, Diagnosis, For Carers (mostly), For Nurses and Therapists (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, RCN, Statistics, UK, Universal Interest | Tagged Assessment and Diagnosis, Cognitive Assessment, Confusion (Delirium), Delirium Diagnosis, Delirium Prevention, Delirium Prevention and Management, Delirium Superimposed on Dementia, Dementia Service Development Centre: University of Stirling, Dementia Services Development Centre (University of Stirling), Diagnosis and Assessment, Diagnosis and Referral, Diagnosis and Support, Diagnosis of Dementia, Differential Diagnosis, Differential Diagnosis of Memory Problems, DSDC: Stirling Dementia Services Development Centre, Early Diagnosis, Early Differential Diagnosis, Improving Diagnosis, Misdiagnosis, Nursing Times, Nursing Times Learning, Post‐Diagnosis Support, Prevention & Early Diagnosis, Recognition of Delirium, Risk Factors for Delirium, Stirling Dementia Services Development Centre (DSDC) Virtual Care Home, Three Ds: Dementia Delirium and Depression, University of Stirling, University of Stirling's Dementia Services Development Centre | Leave a comment

Skin Cells: A New Non-Invasive Biomarker? (BBC News / American Academy of Neurology)

Posted on March 2, 2015 by Dementia and Elderly Care News

Summary Skin may be a good candidate biomarker for detecting hidden brain disorders earlier. Abnormal proteins which accumulate in the brain in neurodegenerative disorders such as Alzheimer’s Disease and Parkinson’s Disease can be found in the skin too. Research is … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Parkinson's Disease, Quick Insights, Universal Interest | Tagged Abnormal Proteins, Abnormal Proteins (Alpha-Synuclein), Abnormal Proteins (Tau), Alzheimer's Disease: Diagnosis, American Academy of Neurology, American Academy of Neurology’s 67th Annual Meeting (Washington 2015), Assessment and Diagnosis, BBC Health News, Biomarkers, Central Hospital at the University of San Luis Potosi, Dementia Diagnosis, Diagnostic Markers, Diagnostic Testing, Differential Diagnosis, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Differential Diagnosis, α-Synuclein, α-Synuclein Aggregation, Mexico, National Council of Science and Technology of Mexico, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Non-Invasive Biomarkers, Parkinson’s Disease Diagnosis, Parkinsonism, Post-Mortem Studies, Skin Biopsies, Skin Cells, Skin Tests, Synucleinopathy, Tau, Tau Pathology, Tau Protein, Timely Diagnosis, University of San Luis Potosi (Mexico) | Leave a comment

Parkinson’s Disease Diagnosis Using Breath Test? (BBC News / Parkinsonism and Related Disorders)

Posted on February 12, 2015 by Dementia and Elderly Care News

Summary There are early hopes for a simple breath test to assist in the early detection and diagnosis of Parkinson’s Disease, based on non-invasive biomarkers in the form of exhaled volatile organic compounds (VOCs). Full Text Link Reference Roberts, M. … Continue reading →

Further Dementia Diagnostic Test Accuracy Systematic Review Protocols (Cochrane Database)

Posted on August 29, 2014 by Dementia and Elderly Care News

Summary This is an additional list of diagnostic testing-related protocols, further to the Cochrane Dementia and Cognitive Improvement Group (CDCIG) Diagnostic Test Accuracy (DTA) protocols and protocol templates listed earlier in Generic Protocol(s) for Diagnostic Test Accuracy Reviews in Dementia … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Models of Dementia Care, NIHR, Systematic Reviews, UK | Tagged 11C-PIB-PET, 18FDG-PET, 6-Item Cognitive Impairment Test (6-CIT), Abbreviated Mental Test (AMT), Addenbrooke's Cognitive Exaination-Revised (ACE-R), ALOIS: the Cochrane Dementia and Cognitive Improvement Group, APOE e4 (Apolipoprotein E e4), APOE-4 Allele, Asymptomatic Alzheimer’s Disease, Blessed Information-Memory-Concentration Test (Blessed I-M-C), Brain Imaging, Bristol University, Canada, CDCIG: Cochrane Dementia and Cognitive Improvement Group, Central and North West London NHS Foundation Trust, China, China Medical University, Clinical Cooperation Unit Nuclear Medicine (Heidelberg), Clock Drawing Test (CDT), Cochrane Dementia and Cognitive Improvement Group (CDCIG), Cochrane Diagnostic Test Accuracy (DTA) Dementia Reviews, Cochrane Diagnostic Test Accuracy (DTA) Reviews, Cochrane Diagnostic Test Accuracy Review Unit (DTA Unit), Cognitive Assessments / Screening Tools, CSF (Cerebrospinal Fluid Analysis of Amyloid Beta and Tau), CSF Tau, CSF Tau / ABeta Ratio, Department of Neurology: VU University Medical Centre Amsterdam, Devon, Diagnostic Test Accuracy (DTA) Handbook, Diagnostic Test Accuracy Reviews, Differential Diagnosis, Differential Diagnosis of Alzheimer’s Disease, Dopamine Transporter Imaging, Dopamine Transporter Imaging (for Diagnosis of DLB), DTA Handbook, Early Differential Diagnosis, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta: Neuroepidemiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, FP-CIT (Fluoropropyl-Carbomethoxy-3b-(4-Iodophenyl)Tropane), Frenchay Hospital (Bristol), Frontotemporal Dementia (FTD), Generic Protocols for Cross-Sectional and Delayed-Verification Studies, German Cancer Research Center: Medical PET Group - Biological Imaging, Germany, Glasgow Royal Infirmary, GP-Cog, Imaging, Imperial College London, Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), Institute of Cardiovascular and Medical Sciences: Glasgow, Institute of Cardiovascular and Medical Sciences: University of Glasgow, Institute of Health Research: Exeter, Institute of Public Health (Cambridge UK), Institute of Public Health (IPH), Institute of Public Health: Cambridge, IRCCS Fatebenefratelli (Brescia), Italy, John Radcliffe Hospital, LITA Polo Universitario, Maastricht University, Maastricht University: Department of Psychiatry and Neuropsychology, Mini-Cog, Modified Mini-Mental State Examination (3-MS), MRI, MRI Brain Imaging, MRI Scans, National Institute for Health Research (NIHR) Cochrane Collaboration Programme, Netherlands, Neuroimaging in Dementia Diagnosis, Neuropsychological Tests for Alzheimer’s Disease Diagnosis, Neuropsychological Tests for Dementia Diagnosis, North Bristol NHS Trust, Nuffield Department of Clinical Neurosciences (Oxford), Nuffield Department of Clinical Neurosciences: University of Oxford, Nuffield Department of Medicine (Oxford), Older People and Healthy Ageing Service Line (London), OPTIMA (Oxford Project to Investigate Memory and Ageing), OPTIMA (Oxfordshire UK), Ospedale Luigi Sacco, Oxford, Oxford Health NHS Foundation Trust, Oxford University Hospitals NHS Trust, Oxford University Medical School, PenCLAHRC, Peninsula CLAHRC, Peninsula Technology Assessment Group (PenTAG), PET-FDG (Positron Emission Tomography F-Fluorodeoxyglucose), PET-PiB (Positron Emission Tomography-Pittsburgh Compound B), Plasma and Cerebrospinal Fluid (CSF) Abeta42, Positron Emission Tomography (PET), Protocols, Public Health Epidemiology and Biostatistics: Birmingham, Queen's University (Canada), Radcliffe Department of Medicine, ratio, rCBF SPECT, Research Protocol, School for Mental Health and Neuroscience: Maastricht University, Shengjing Hospital, sMRI (Structural Magnetic Resonance Imaging), SPECT (Single Photon Emission Computed Tomography), St Louis University Mental Status Examination (SLUMS), Study Protocol, Sunnybrook Health Sciences Centre (Toronto), Systematic Reviews and Meta-Analyses, Test Your Memory (TYM), University Hospitals Bristol, University of Birmingham, University of Bristol, University of Cambridge, University of Exeter, University of Exeter Medical School, University of Glasgow, University of Milan, University of Oxford, University of Toronto, VU University (Netherlands), VU University Medical Centre | Leave a comment

Concerning the Diagnostic Accuracy of Plasma and CSF Biomarkers (Cochrane Database)

Posted on August 2, 2014 by Dementia and Elderly Care News

Summary This systematic review investigates the diagnostic accuracy of blood plasma and CSF Aß levels for detecting patients with mild cognitive impairment (MCI) and who are likely to progress to Alzheimer’s Disease or other types of dementia. The accuracy of … Continue reading →

Posted in Charitable Bodies, Diagnosis, For Doctors (mostly), For Researchers (mostly), International, Systematic Reviews, UK | Tagged Aß40, Aß42, ALOIS: the Cochrane Dementia and Cognitive Improvement Group, Alzheimer's Association, Alzheimer's Disease and Related Disorders Association (Now the Alzheimer's Association), Alzheimer’s Disease Biomarkers, Amyloid, Amyloid Beta, Amyloid Beta Protein, Amyloid Proteins, Amyloid-β (Aβ), Apolipoprotein E, Asymptomatic Alzheimer’s Disease, Beta-Amyloid, Beta-Amyloid Plaques, Biomarker Assessments in Alzheimer’s Disease, Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Blood-Based Biomarkers, Cambridge Institute of Public Health, Cambridge Institute of Public Health: Cambridge University, Candidate Blood Proteome Markers, Cerebrospinal Fluid, Cerebrospinal Fluid (CSF), Cerebrospinal Fluid (CSF) Biomarkers, Cochrane Database, Cochrane Database of Systematic Reviews, Cochrane Dementia and Cognitive Improvement Group, Cochrane Register of Diagnostic Test Accuracy Studies, Cognitive Impairment, Cognitive Response to Progression of Pathophysiology, Conversion to Dementia From Prodromal Disease, CSF Aß Levels, CSF Aβ, CSF Biomarkers, CSF Tau, Dementia Screening, Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV), Diagnostic Test Accuracy, Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Differential Diagnosis, Early Screening, Fluid and Imaging Biomarkers, Imperial College London, Institute of Public Health: University of Cambridge, β-amyloid, β-Amyloid 1-42 (Aβ42), MCI: Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), National Institute of Neurological and Communicative Disorders and Stroke, Neurodegeneration, NINCDS-ADRDA Criteria, NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer Disease and Related Disorders Association, Plasma Biomarkers, Plasma Proteins, Preclinical Alzheimer's Disease, Prodromal Alzheimer's Disease, Progression of Mild Cognitive Impairment to Dementia, Systematic Reviews and Meta-Analyses, Transition from Cognitive Impairment to Dementia, University of Birmingham, University of Cambridge, University of Oxford, University of Oxford: Radcliffe Department of Medicine, University of Western Australia, US Alzheimer's Association, Western Australian Centre for Health and Ageing (WACHA) | Leave a comment

Blood Test Potentially Able to Predict Alzheimer’s Disease Onset (BBC News / Alzheimer’s & Dementia)

Posted on July 8, 2014 by Dementia and Elderly Care News

Summary Research published in the Alzheimer’s & Dementia: the Journal of the Alzheimer’s Association may indicate a significant step forwards in developing a blood test which could be able to predict the risk of Alzheimer’s Disease onset with 87% accuracy. Research … Continue reading →

New Blood Test May Predict Alzheimer’s Disease Onset (BBC News / NHS Choices / Nature Medicine)

Posted on March 10, 2014 by Dementia and Elderly Care News

Summary Researchers at Georgetown University in Washington DC claim to have devised a new blood test which promises to be able to predict the risk of Alzheimer’s Disease onset with 90% accuracy. The test is based on the levels of 10 … Continue reading →

Posted in BBC News, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged Alzheimer's Disease: Diagnosis, Alzheimer’s Early Screening, Amnestic Mild Cognitive Impairment (aMCI), Assessment and Diagnosis, BBC Health News, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Blood Tests, Blood-Based Biomarkers, Case Finding, Cell Membrane Integrity, Cognitive Decline Studies, Cognitive Impairment, Dementia Case Finding, Dementia Diagnosis, Dementia Screening, Diagnosis, Diagnosis of Alzheimer's Disease, Diagnostics, Differential Diagnosis, Early Detection of Preclinical Disease, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Differential Diagnosis, Early Screening, Georgetown University, Georgetown University Medical Center, Georgetown University Medical Center (GUMC), Late-Life Cognitive Decline, Lipids, MCI: Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), National Institutes of Health (NIH), National Institutes of Health (US), Nature Medicine, Non-Invasive Biomarkers, Plasma Phospholipids, Preclinical Alzheimer's Disease, Rapid Screening, Screening, Screening for Dementia, Screening Tools for Amnestic Mild Cognitive Impairment (a-MCI), United States, Unity Health System: Rochester (USA), University of California: Irvine School of Medicine, USA | Leave a comment

Blood Test for Early Detection of Alzheimer’s Disease? (BBC News / Genome Biology)

Posted on July 30, 2013 by Dementia and Elderly Care News

Summary The degenerative processes causing Alzheimer’s Disease are believed to start often years before clinical symptoms become apparent. Researchers have been investigating ways of detecting the disease earlier. Such tests should help in learning more about how the disease progresses. Tests … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, Universal Interest | Tagged Alzheimer's Disease: Diagnosis, Alzheimer’s Early Screening, Assessment and Diagnosis, BBC Health News, Blood Tests, Dementia Diagnosis, Dementia Screening, Diagnosis, Diagnosis of Alzheimer's Disease, Diagnostics, Differential Diagnosis, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Differential Diagnosis, Early Screening, Genetic Profiling, Genetic Tests, Genetics of Alzheimer's Disease, Genome Biology, Germany, Innovation in Genetics, microRNA, MicroRNAs, Rapid Screening, Saarland University, Screening, Screening for Dementia | Leave a comment

COGNISION™ for Neurological Disorders Including Dementia (NIHR)

Posted on June 19, 2013 by Dementia and Elderly Care News

Summary The COGNISION™ system, developed by Neuronetrix, is intended to assist in the diagnosis and evaluation of Alzheimer’s Disease, dementia and other neurological disorders. It uses non-invasive detection of differences in the neural processing of auditory stimuli in people with … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Researchers (mostly), National, NIHR, Quick Insights, UK | Tagged Alzheimer's Disease: Diagnosis, Assessment and Diagnosis, Auditory Event-Related Potentials (ERPs), Birmingham, COGNISION™ (Neuronetrix), COGNISION™ System, Diagnosis and Assessment, Diagnosis of Dementia, Early Diagnosis, Early Differential Diagnosis, National Institute for Health Research (NIHR), Neuronetrix, NIHR Horizon Scanning Centre (NIHR HSC), NIHR HSC Technology Alerts, Quantitative Electroencephalography (qEEG) System (COGNISION™), Timely Diagnosis, University of Birmingham, University of Birmingham: NIHR HSC, West Midlands | Leave a comment

Tag Archives: Early Differential Diagnosis

Cognitive Assessment: Differentiating the Three Ds “Dementia, Delirium and Depression” (Nursing Times / University of Stirling DSDC)

Skin Cells: A New Non-Invasive Biomarker? (BBC News / American Academy of Neurology)

Further Dementia Diagnostic Test Accuracy Systematic Review Protocols (Cochrane Database)

Blood Test Potentially Able to Predict Alzheimer’s Disease Onset (BBC News / Alzheimer’s & Dementia)

New Blood Test May Predict Alzheimer’s Disease Onset (BBC News / NHS Choices / Nature Medicine)

Blood Test for Early Detection of Alzheimer’s Disease? (BBC News / Genome Biology)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites